Identification of Risk Phenotypes for Sarcopenia Using DXA WBC, Anthropometric and MA Among Young Adults

Active, not recruiting

• Conditions: Sarcopenia

• Registration Number: NCT06739850
• Lead Sponsor: Superior University

Brief Summary

This cross-sectional study aims to identify risk phenotypes for sarcopenia among young adults using Dual-energy X-ray Absorptiometry (DXA) for whole-body composition analysis, along with anthropometric and musculoskeletal assessments. Sarcopenia, characterized by the loss of muscle mass and strength, is a growing concern, particularly among the aging population.

Detailed Description

However, early identification in young adults can allow for preventive strategies to improve long-term health outcomes. This study, involving 221 participants aged 15 to 35, focuses on assessing the correlation between DXA-derived body composition, musculoskeletal fitness, and anthropometric measurements with sarcopenia risk. Primary outcome measures include DXA imaging and dynamometry for body composition and strength evaluation, while secondary outcomes focus on detailed anthropometric and musculoskeletal analyses. By addressing early risk factors in younger populations, this research hopes to enhance understanding of sarcopenia's development and support early intervention strategies. Data collection is conducted at the Center of Nuclear Medicine in Lahore, Pakistan.

Study Timeline

• Study Start: 2024-02-28
• Primary Completion: 2024-05-31
• Status Verified: 2024-12
• Study First Submitted: 2024-12-14
• Study First Submitted QC: 2024-12-14
• Last Update Submitted: 2024-12-14
• Study First Posted: 2024-12-18
• Last Update Posted: 2024-12-18
• Study Completion: 2025-03-01

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 221

Inclusion Criteria

• Young Adults ( between 15-35) (7)

Exclusion Criteria

• Elderly Patients
• Children below the age of 18 Years
• Diagnosed Malignancy
• Diagnosed Patients
• Diseased Individuals such as Chronic Illness and Malignancies

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
DXA	12 Months	DXA Whole Body Imaging is a primary tool of measure for my study

Trial Locations

Locations (1)

CENUM Center Mayo Hospital Rd, Anarkali Bazaar; 🇵🇰 Lahore, Punjab, Pakistan